search
Back to results

Launching a Salt Substitute to Reduce Blood Pressure at the Population Level in Peru

Primary Purpose

Blood Pressure, Hypertension

Status
Completed
Phase
Not Applicable
Locations
Peru
Study Type
Interventional
Intervention
Salt substitute
Sponsored by
Universidad Peruana Cayetano Heredia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Blood Pressure focused on measuring Blood pressure, Hypertension, Stepped wedge trial design

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Males or females aged 18 years and over from the randomly selected villages.
  • Capable of understanding study procedures and providing informed consent.
  • Full-time resident in the area.

Exclusion Criteria:

  • Self-reported history of chronic kidney disease or heart disease.
  • Refusal to participate.

Sites / Locations

  • Center for Global Health (Universidad Peruana Cayetano Heredia)

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Salt substitute

Arm Description

As described by Brown, in a stepped wedge design, an intervention is rolled-out sequentially to the trial participants (either as individuals or clusters of individuals) over a number of time periods. The order in which the different individuals or clusters receive the intervention is determined at random and, by the end of the random allocation, all individuals or groups will have received the intervention. Stepped wedge designs incorporate data collection at each point where a new group (step) receives the intervention. Thus, the salt substitute will be implemented in each cluster (village) in a randomized fashion. Not arms are needed since the 6 randomly-selected villages will be implemented in some moment of the protocol.

Outcomes

Primary Outcome Measures

Systolic/diastolic blood pressure (mmHg)
We will assess changes in systolic and diastolic blood pressure over time. Periodic assessments will be carried out to obtain clinical measurements. Every five months, a new evaluation will be performed in all participant villages (intervention and control). Systolic and diastolic blood pressure will be measured in triplicate using standard procedures and automated and validated devices. These periodic assessments will be taken at each household to guarantee contact with each family member enrolled in this study.

Secondary Outcome Measures

Progression to hypertension
Using data of systolic and diastolic blood pressure, we will estimate progression towards hypertension among participants in intervened and control villages.

Full Information

First Posted
October 7, 2013
Last Updated
August 22, 2021
Sponsor
Universidad Peruana Cayetano Heredia
Collaborators
Johns Hopkins University
search

1. Study Identification

Unique Protocol Identification Number
NCT01960972
Brief Title
Launching a Salt Substitute to Reduce Blood Pressure at the Population Level in Peru
Official Title
Launching a Salt Substitute to Reduce Blood Pressure at the Population Level - Peru
Study Type
Interventional

2. Study Status

Record Verification Date
August 2021
Overall Recruitment Status
Completed
Study Start Date
March 2014 (Actual)
Primary Completion Date
March 2017 (Actual)
Study Completion Date
April 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad Peruana Cayetano Heredia
Collaborators
Johns Hopkins University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This protocol aims to implement, using a stepped wedge trial design, a population-level intervention to replace high-sodium salt for a salt substitute (low-sodium, high-potassium salt) to reduce blood pressure levels among adults aged 18 years and over of the semi-urban area of Tumbes. We hypothesize that participants aged 18 years and over from villages receiving a salt substitute will have lower blood pressure compared to control villages.
Detailed Description
Several randomized clinical trials and meta-analysis have reported that reduction of sodium intake decreases blood pressure. Also, the increase of potassium ingestion in minimal doses has been found in systematic reviews to produce a small reduction in blood pressure levels. The proposed intervention is a community-wide mass-strategy in which direct delivery of a salt substitute to households is accompanied by wide social marketing campaigns, both before and during the intervention period. With this experimental stepped wedge trial design, we will estimate the impact of a reduced-sodium salt substitution program on blood pressure at the population level. We propose the following specific aims: Specific Aim 1: To implement and assess the impact of an intervention using a salt substitute on blood pressure at the population level using a stepped wedge trial design. Specific Aim 2: To determine costs and efficacy of this implementation strategy using cost-effectiveness analysis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Blood Pressure, Hypertension
Keywords
Blood pressure, Hypertension, Stepped wedge trial design

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
2376 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Salt substitute
Arm Type
Experimental
Arm Description
As described by Brown, in a stepped wedge design, an intervention is rolled-out sequentially to the trial participants (either as individuals or clusters of individuals) over a number of time periods. The order in which the different individuals or clusters receive the intervention is determined at random and, by the end of the random allocation, all individuals or groups will have received the intervention. Stepped wedge designs incorporate data collection at each point where a new group (step) receives the intervention. Thus, the salt substitute will be implemented in each cluster (village) in a randomized fashion. Not arms are needed since the 6 randomly-selected villages will be implemented in some moment of the protocol.
Intervention Type
Other
Intervention Name(s)
Salt substitute
Intervention Description
A salt substitute using 25% of potassium chloride and 75% of sodium chloride will be implemented in each of the villages.
Primary Outcome Measure Information:
Title
Systolic/diastolic blood pressure (mmHg)
Description
We will assess changes in systolic and diastolic blood pressure over time. Periodic assessments will be carried out to obtain clinical measurements. Every five months, a new evaluation will be performed in all participant villages (intervention and control). Systolic and diastolic blood pressure will be measured in triplicate using standard procedures and automated and validated devices. These periodic assessments will be taken at each household to guarantee contact with each family member enrolled in this study.
Time Frame
Three years
Secondary Outcome Measure Information:
Title
Progression to hypertension
Description
Using data of systolic and diastolic blood pressure, we will estimate progression towards hypertension among participants in intervened and control villages.
Time Frame
Three years
Other Pre-specified Outcome Measures:
Title
Cost-effectiveness analysis
Time Frame
Three years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Males or females aged 18 years and over from the randomly selected villages. Capable of understanding study procedures and providing informed consent. Full-time resident in the area. Exclusion Criteria: Self-reported history of chronic kidney disease or heart disease. Refusal to participate.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jaime Miranda, MD, PhD
Organizational Affiliation
Universidad Peruana Cayetano Heredia
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Robert H Gilman, MD
Organizational Affiliation
Johns Hopkins Bloomberg School of Public Health
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Antonio Bernabe-Ortiz, MD, MPH
Organizational Affiliation
Universidad Peruana Cayetano Heredia
Official's Role
Study Director
Facility Information:
Facility Name
Center for Global Health (Universidad Peruana Cayetano Heredia)
City
Tumbes
Country
Peru

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Data can be shared potentially when main papers are published.
Citations:
PubMed Identifier
24667035
Citation
Bernabe-Ortiz A, Diez-Canseco F, Gilman RH, Cardenas MK, Sacksteder KA, Miranda JJ. Launching a salt substitute to reduce blood pressure at the population level: a cluster randomized stepped wedge trial in Peru. Trials. 2014 Mar 25;15:93. doi: 10.1186/1745-6215-15-93.
Results Reference
background
PubMed Identifier
28678190
Citation
Pesantes MA, Diez-Canseco F, Bernabe-Ortiz A, Ponce-Lucero V, Miranda JJ. Taste, Salt Consumption, and Local Explanations around Hypertension in a Rural Population in Northern Peru. Nutrients. 2017 Jul 5;9(7):698. doi: 10.3390/nu9070698.
Results Reference
result
PubMed Identifier
26225848
Citation
Saavedra-Garcia L, Bernabe-Ortiz A, Gilman RH, Diez-Canseco F, Cardenas MK, Sacksteder KA, Miranda JJ. Applying the Triangle Taste Test to Assess Differences between Low Sodium Salts and Common Salt: Evidence from Peru. PLoS One. 2015 Jul 30;10(7):e0134700. doi: 10.1371/journal.pone.0134700. eCollection 2015.
Results Reference
result
PubMed Identifier
32066973
Citation
Bernabe-Ortiz A, Sal Y Rosas VG, Ponce-Lucero V, Cardenas MK, Carrillo-Larco RM, Diez-Canseco F, Pesantes MA, Sacksteder KA, Gilman RH, Miranda JJ. Effect of salt substitution on community-wide blood pressure and hypertension incidence. Nat Med. 2020 Mar;26(3):374-378. doi: 10.1038/s41591-020-0754-2. Epub 2020 Feb 17.
Results Reference
result

Learn more about this trial

Launching a Salt Substitute to Reduce Blood Pressure at the Population Level in Peru

We'll reach out to this number within 24 hrs